UNSPSC 85891558: High dose rate (hdr) brachytherapy of axillary lymphatics using iodine 125 (i-125)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of axillary lymphatics using iodine 125 (i-125). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D71499Z

UNSPSC 85891558 High dose rate (hdr) brachytherapy of axillary lymphatics using iodine 125 (i-125) is a Commodity code that nominally describes a specialized radiation oncology procedure, but the recent state and local procurement activity tagged to this code does not align with that scope. The single recent opportunity in the source—the County of Santa Clara Health System's RFQ for temporary health professional staffing services across multiple ancillary clinical categories (posted July 7, 2026, with responses due October 7, 2026)—involves staffing placement in audiology, radiology, respiratory care, surgical services, and related non-clinical roles, not brachytherapy treatment delivery or radiation oncology. The mismatch suggests either a tagging error in the procurement data or that the code is being applied to health system workforce services broadly rather than the specific therapeutic procedure its name denotes. State and local health systems do procure clinical staffing through temporary-vendor qualification vehicles, but this particular opportunity bears no relation to brachytherapy as a product or service line.

The source provides no evidence of other recent state or local opportunities under this code and no geographic concentration beyond Santa Clara County, California. The single posting represents a non-exclusive, multiple-award qualification model with no guaranteed work volume and a five-year vendor list retention period. Without additional opportunities or a clearer alignment between the code's nominal scope and actual procurement demand, this code shows little actionable activity for business development professionals pursuing state and local contracts in cancer treatment, radiation oncology, or related medical device and services sectors.